Ireland
--:--IST
Active, not recruiting Not applicable

Evaluation of e New Sleep Detection Device "Easy Sleep Monitoring"

NCT05696496 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2023-01-25
Last updated
2025-09-26

Condition(s) studied

Sleep Disorder

Investigational drug(s) / intervention(s)

night recording

night recording: The patients/controls will arrive in the evening at the Sleep Laboratory (Functional Exploration Department of the Nervous System of the Clermont-Ferrand University Hospital) to carry out complete vPSG and test the new ESM "intelligent duvet"device. A qualified technician will place the electrodes according to the procedures usually followed at the Sleep Center for vPSG recording. The ESM duvet will be placed on the patient's body as a blanket, instead of the blankets normally provided by the hospital. Patients/controls will be monitored overnight by an infrared video camera.

Study summary

If the video-polysomnographic (vPSG) recording in the laboratory remains the reference examination in Sleep Medicine Centers for the diagnosis of sleep pathologies, the high prevalence of sleep disorders in the general population and the growing demand for exploration and management may require the use of alternative techniques such as new sleep recording or analysis devices. In collaboration with the Creative Mechatronics Company (Issoire) and the Ennery Confection Company (Le Puy en Velay), we have developed a "portable" sleep detection prototype called Easy Sleep Monitoring (ESM) which consists of an "intelligent" duvet equipped with a series of sensors capable of detecting movements and, through this, estimating sleep duration and quantifying motor phenomena during sleep. Indeed, it is a duvet which has in its thickness a grid of 35 electronic cards, equipped with an actimetric sensor and a temperature sensor. The distribution of the sensors makes it possible to detect the motor activity of the sleeper on all the body regions by considerably increasing the sensitivity and specificity compared to actimetry at the wrist.

The advantage of this duvet compared to other "wearable" devices is represented by its ease of use, being less restrictive, having a reduced implementation time and not requiring the user's collaboration. For example, it could be used for sleep monitoring in the elderly and/or in a situation of hypomobility in the context of Residential establishment for dependent elderly people or hospitals. At home, it could be a sleep monitoring tool, such as monitoring treatment for insomnia, medicinal or not, or to monitor motor activity during sleep, as in the monitoring of nocturnal akinesia in parkinsonian patients.

The main objective of this study is to evaluate the concordance of sleep data obtained with the ESM duvet with those obtained by video-polysomnography (vPSG). Indeed, the vPSG is the gold standard examination in the study of sleep, the only one capable of exactly defining the different stages of sleep and precisely quantifying sleep disorders.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
Accepted
Inclusion Criteria: For Sleep Disorder Group (TS+): * Men or women, aged 18 to 85 * With a suspected sleep disorder (sleep apnea, restless legs syndrome RLS, syndrome of periodic leg movements during MPJS sleep, REM sleep behavior disorder, Parkinson's disease, Narcolepsy, etc.), requiring a confirmation of the diagnosis in vPSG. * Cooperation and understanding to strictly comply with the conditions set out in the protocol - Acceptance of the protocol and signing of a written consent * Affiliation to the social security system For Control Group (TS- ): * Men or women, aged 18 to 85 * Having no sleep disorder: the Pittsburgh PSQI sleep quality index (Buysse et al., 1989) must be \<5. * Cooperation and understanding to strictly comply with the conditions set out in the protocol - Acceptance of the protocol and signing of a written consent * Affiliation to the social security system Exclusion Criteria: For Group TS+ and TS-: * Patients under guardianship or curatorship or safeguard of justice * Pregnant or breastfeeding women (given the low risk incurred, the verification will be done on simple declaration of the patient) * Patients with active implants * during a period of exclusion from another study, * refusing to participate in the study

Primary outcome measure(s)

  • Effective sleep duration (in minutes) — Month 6
    evaluated by vPSG
  • Effective sleep duration (in minutes) — Month 6
    evaluated by ESM device

Trial sites (1)

FacilityCityRegionStatus
CHU Clermont-Ferrand, UMR INSERM 1107 Clermont-Ferrand France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05696496 on ClinicalTrials.gov ↗ ← All trials in France